Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -580 | -150 | -1,460 | 0 | 0 |
| Depreciation Amortization | 390 | 190 | 890 | 0 | 0 |
| Income taxes - deferred | 0 | 0 | -381 | 0 | 0 |
| Accounts receivable | 0 | 0 | 304 | 0 | 0 |
| Accounts payable and accrued liabilities | 0 | 0 | -503 | 0 | 0 |
| Other Working Capital | 1,900 | 870 | -830 | 0 | 0 |
| Other Operating Activity | 10 | 10 | 650 | 0 | 0 |
| Operating Cash Flow | $1,720 | $920 | $-1,330 | $0 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -50 | -20 | -190 | 0 | 0 |
| Investing Cash Flow | $-50 | $-20 | $-190 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 0 | 187 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | -104 | 0 | 0 |
| Other Financing Activity | 0 | 0 | -3 | 0 | 0 |
| Financing Cash Flow | $0 | $0 | $80 | $0 | $0 |
| Beginning Cash Position | 130 | 130 | 1,570 | 0 | 0 |
| End Cash Position | 1,800 | 1,030 | 130 | 0 | 0 |
| Net Cash Flow | $1,660 | $900 | $-1,440 | $0 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,720 | 920 | -1,330 | 0 | 0 |
| Capital Expenditure | 0 | 0 | -194 | 0 | 0 |
| Free Cash Flow | 1,720 | 920 | -1,524 | 0 | 0 |